Clik here to view.
Nanomix Receives CE Mark for Diagnostic Panel That Aids in Rapid...
EMERYVILLE, Calif. Nanomix announced today that the company has received CE Mark for its S1 Assay for the rapid, simultaneous detection and quantification of lactate (LAC), procalcitonin (PCT), and...
View ArticleClik here to view.
OncoSec Comments on Disturbing Elements of Alpha Holdings’ Revised...
SAN DIEGO & PENNINGTON, N.J. OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, issued a statement...
View ArticleClik here to view.
Macrogen Research Outcome from ‘GenomeAsia 100K’ Covered in Nature
SEOUL, South Korea The precision medicine and biotechnology company Macrogen (Chairman Jung-Sun Seo, www.macrogen.com) (KOSDAQ: 038290) announced on Dec 5 that the result of its Asian genome...
View ArticleClik here to view.
Macrogen通过GenomeAsia 100K国际联盟获得的研究成果作为《自然》杂志正刊封面论文刊载
韩国首尔 (美国商业资讯)–精密医学生命工程企业Macrogen(会长徐正善 www.macrogen.com)(KOSDAQ: 038290)于5日发布消息称，其通过国际联盟“GenomeAsia 100K倡议（GenomeAsia 100K Initiative）”获得的亚洲人基因组分析研究成果已作为封面论文，刊载于最新一期的《自然（Nature）》杂志上。（论文名称：The...
View ArticleClik here to view.
マクロジェン、ゲノムアジア 100K 国際コンソーシアムの研究成果がネイチャー誌の巻頭論文として掲載
韓国ソウル （ビジネスワイヤ） – 精密医療・バイオテクノロジー企業であるマクロジェン（会長：ソ・ジョンソン, www.macrogen.com)(KOSDAQ: 038290)は国際コンソーシアムである「ゲノムアジア 100K イニシアチブ（GenomeAsia 100K...
View ArticleClik here to view.
AJC Organized the ASEAN Services Trade Forum in Tokyo to Discuss the Emerging...
TOKYO The ASEAN-Japan Centre (AJC) held the “ASEAN Services Trade Forum – Health and Social Services –” on 27 November 2019 in Tokyo, Japan. 107 participants from Japanese private sector, government...
View ArticleClik here to view.
LYNPARZA® (olaparib) Approved in China as a First-Line Maintenance Therapy in...
KENILWORTH, N.J. AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the companies have received marketing authorization from China’s National...
View ArticleClik here to view.
2019年台湾医疗科技展展商简介
台湾台北 (美国商业资讯)–台湾医疗科技展(Healthcare+ Expo Taiwan)将于2019年12月5日至8日在台湾台北市的南港展览馆举行。 美国商业资讯是台湾医疗科技展的官方媒体合作伙伴。以下列出部分参展商资料，展商新闻和公告可在http://www.tradeshownews.com/events/Healthcare-Expo-Taiwan-2019/查询。 参展单位：...
View ArticleClik here to view.
Taro Announces Resignation of Chief Financial Officer
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) announced today that it has accepted the resignation of its Chief Financial Officer, Mariano Balaguer,...
View ArticleClik here to view.
Metro Pacific Hospitals Completes Investment by KKR
MANILA, Philippines Metro Pacific Investments Corporation (“MPIC”) (PSE: MPI), global investment firm KKR, and GIC, Singapore’s sovereign wealth fund, today announced the completion of investments...
View ArticleClik here to view.
Evaluate Ltd. appoints Martyn Hindley as Chief Financial Officer
LONDON & BOSTON & TOKYO Evaluate Ltd., the leading provider of commercial data to the life sciences industry, is pleased to announce the appointment of Martyn Hindley as Chief Financial...
View ArticleClik here to view.
Maruho和Solasia签署SP-04(PledOx®)代理许可及资本联盟协议
日本东京 (美国商业资讯)–苏爱康制药有限公司（东京证券交易所代码：4597，总部：日本东京，总裁兼首席执行官：荒井好裕，以下简称“苏爱康”）和Maruho有限责任公司（总部：日本大阪，总裁兼首席执行官：Koichi Takagi,...
View ArticleClik here to view.
ソレイジア・ファーマ: 開発品SP-04(効能・効果：がん化学療法に伴う末梢神経障害) 日本における独占的販売ライセンス契約締結および資本提携のお知らせ
東京 （ビジネスワイヤ） — マルホ株式会社（以下「マルホ」）とソレイジア・ファーマ株式会社（以下「ソレイジア」）は、ソレイジアが開発している開発品SP-04...
View ArticleClik here to view.
Solasia Announces License and Capital Alliance for SP-04 (PledOx®) with Maruho
TOKYO Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) announced today that it has entered into an exclusive license agreement...
View ArticleClik here to view.
PolarityTE Builds Patent Portfolio with New International Patent Grants
SALT LAKE CITY PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that the company has recently...
View ArticleClik here to view.
DKT Expands Access to Contraceptives for Safe Sex as HIV/AIDS Impacts 37...
WASHINGTON According to UNAIDS, “Condoms, if easily available and used consistently and correctly, are one of the most effective and inexpensive methods available to reduce the sexual transmission...
View ArticleClik here to view.
Korean CDISC Coordinating Committee Launched at 2019 Korea Summit
AUSTIN, Texas CDISC is pleased to announce the launch of the Korea CDISC Coordinating Committee (K3C) at the 2019 CDISC Korea Summit held 7 November in Daegu, South Korea. Dr. Maria Im Hee Shin of...
View ArticleClik here to view.
DS-8201 ([Fam-] Trastuzumab Deruxtecan) Achieved A Tumor Response Rate of...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today presented positive detailed data from the global pivotal phase 2...
View ArticleClik here to view.
OPTOLANE Chooses Trustonic to Protect New Connected Medical Diagnostic Devices
CAMBRIDGE, England Device and application security leader Trustonic today announces that OPTOLANE has selected Trustonic Secured Platform (TSP) to bring security and trust to the company’s new...
View ArticleClik here to view.
PCI Pharma Services宣布巨额投资，扩建位于英国Tredegar厂区的开发和制造能力
费城 (美国商业资讯)–领先的制药和生物制药全球外包解决方案提供商PCI Pharma Services (PCI)今天宣布，已开始扩建其位于英国威尔士的Tredegar设施，以提升其高效价药物制造和开发能力，包括临床和商业两方面的供货。...
View Article